CH616943A5 - - Google Patents

Download PDF

Info

Publication number
CH616943A5
CH616943A5 CH1273676A CH1273676A CH616943A5 CH 616943 A5 CH616943 A5 CH 616943A5 CH 1273676 A CH1273676 A CH 1273676A CH 1273676 A CH1273676 A CH 1273676A CH 616943 A5 CH616943 A5 CH 616943A5
Authority
CH
Switzerland
Prior art keywords
ala
glu
functions
isoglutamine
alanyl
Prior art date
Application number
CH1273676A
Other languages
English (en)
French (fr)
Inventor
Arlette Adam
Pierre Lefrancier
Edgar Lederer
Original Assignee
Anvar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anvar filed Critical Anvar
Publication of CH616943A5 publication Critical patent/CH616943A5/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/826Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CH1273676A 1975-10-09 1976-10-07 CH616943A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7530948A FR2326930A1 (fr) 1975-10-09 1975-10-09 Agents hydrosolubles depresseurs non specifiques des reponses immunitaires

Publications (1)

Publication Number Publication Date
CH616943A5 true CH616943A5 (xx) 1980-04-30

Family

ID=9161007

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1273676A CH616943A5 (xx) 1975-10-09 1976-10-07

Country Status (10)

Country Link
US (1) US4101649A (xx)
JP (1) JPS5257120A (xx)
AU (1) AU522089B2 (xx)
BE (1) BE847103A (xx)
CA (1) CA1091651A (xx)
CH (1) CH616943A5 (xx)
DE (1) DE2645610C2 (xx)
FR (1) FR2326930A1 (xx)
GB (1) GB1562734A (xx)
NL (1) NL7611088A (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU727647A1 (ru) * 1977-11-02 1980-04-15 Институт биоорганической химии им.М.М.Шемякина Гликопептиды,обладающие противоопухолевой активностью и способ их получени
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
US4391800A (en) * 1979-04-27 1983-07-05 Merck & Co., Inc. Immunologically active peptidyl disaccharides and methods of preparation
US4310514A (en) * 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
US4357322A (en) * 1980-07-29 1982-11-02 Syntex (U.S.A.) Inc. Method of preventing, reducing or inhibiting inflammation
JPS5920297A (ja) * 1982-07-27 1984-02-01 Dai Ichi Seiyaku Co Ltd ムラミルジペプチド誘導体
US4765980A (en) * 1986-04-28 1988-08-23 International Minerals & Chemical Corp. Stabilized porcine growth hormone
SI9300212A (en) * 1993-04-22 1994-12-31 Univ Ljubljani Novel N-acyldipeptides, process for the preparation thereof and pharmaceutical composition containing the same
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879376A (en) * 1971-05-10 1975-04-22 Oreal Chitosan derivative, method of making the same and cosmetic composition containing the same
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
DE2645610A1 (de) 1977-04-21
US4101649A (en) 1978-07-18
FR2326930B1 (xx) 1979-09-14
CA1091651A (en) 1980-12-16
BE847103A (fr) 1977-04-08
JPS5257120A (en) 1977-05-11
AU522089B2 (en) 1982-05-13
AU1867676A (en) 1978-04-20
NL7611088A (nl) 1977-04-13
DE2645610C2 (de) 1984-10-25
FR2326930A1 (fr) 1977-05-06
JPS618079B2 (xx) 1986-03-11
GB1562734A (en) 1980-03-12

Similar Documents

Publication Publication Date Title
EP0318377B1 (fr) Nouveaux composés énantiomères dérivés d'amino-acides, leur procédé de préparation et leurs applications thérapeutiques
CH624124A5 (xx)
JPS6126800B2 (xx)
CH616943A5 (xx)
EP0004512A1 (fr) Composés esters de muramyl-peptide et leurs applications dans les compositions pharmaceutiques et réactifs de laboratoire
CH655936A5 (fr) Derives du 3-amino pregn-5-ene, leurs sels, leur preparation, medicaments et compositions les renfermant.
CH634041A5 (fr) Derives de la pepstatine, leur preparation et composition les contenant.
EP0015810A1 (fr) N-acétyl-L-(N-méthyl-alanyl)-D-isoglutamine et compositions la contenat, pour l'utilisation en tant que régulateurs des mécanismes immunitaires
EP0005658A1 (fr) Nouveaux dérivés de peptides analogues des enképhalines, leur procédé de préparation et leur application thérapeutique
EP0316322B1 (fr) Tetrapeptide inhibiteur de l'entree en cycle des cellules souches hematopo etiques, procedes pour son obtention et ses applications
EP0448550A1 (fr) NOUVEAUX DERIVES DE LA DEOXY-2'-URIDINE SUBSTITUEE EN POSITION 5, 3' ou 5' PAR DES GROUPEMENTS ALPHA-AMINO ACYLES, PROCEDE POUR LEUR OBTENTION ET MEDICAMENTS LES CONTENANT.
EP0006068A2 (fr) Composés du type muramyl-peptide et médicaments les contenant
US4895872A (en) Immunosupressive analogues and derivatives of succinylacetone
FR2491922A1 (fr) Nouveaux hexapeptides, procede pour leur preparation et application comme medicaments
CH626897A5 (xx)
EP0315519B1 (fr) Nouveaux dérivés de l'acide aminopimélique, leur procédé de préparation et leur application comme médicaments
CH637650A5 (fr) Procede de preparation d'un acide chromone carboxylique.
EP0750635B1 (fr) Peptides pour inhiber la liberation de pepsine
CA1140111A (fr) PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE DU (20S) 3.alpha.- /(AMINO-ACETYL)AMINO/ 5.alpha.-PREGNAN-20-OL ET DE SES SELS
LU87696A1 (fr) Peptides sdk,leur procede de preparation ainsi que des compositions therapeutiques en contenant
FR2597107A1 (fr) Tripeptide doue d'une activite immunostimulante
EP0386045B1 (fr) Derives de synergimycines de types a et b
FR2612778A1 (fr) Nouveaux derives d'aminoquinoleine antimalarique, procede de preparation et composition pharmaceutique en contenant
CH619470A5 (en) Process for the preparation of 2-(2-acetamido-2-deoxy-3-O-D-glucopyranosyl)-D-propionyl-L-seryl-D-iso glutamine and 2-(2-acetamido-2-deoxy-3-O-D-glucopyranosyl)-D-propionyl-L-seryl-D-glu tamic acid
LU82545A1 (fr) Derives d'acides acylaminobenzoiques et les compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
PL Patent ceased